BOXED WARNING Concomitant use with opioids: profound sedation, respiratory depression, coma, death. Benzodiazepine abuse, misuse, and addiction (overdose/death). Physical dependence; abrupt discontinuation or rapid dose reduction can cause life-threatening withdrawal.
FDA dosing
Population
Start
Target
Max
Anxiety
Adult
30 mg/day divided (or 15 mg QHS single dose)
15-60 mg/day
Anxiety
Elderly/debilitated
7.5-15 mg/day
individualized
Acute alcohol withdrawal
Adult
Day 1: 30 mg, then 30-60 mg divided
Taper: Day 2 45-90 mg, Day 3 22.5-45 mg, Day 4 15-30 mg, then 7.5-15 mg
90 mg/day
Adjunct to antiepileptic drugs
Adult / >12 yr
7.5 mg TID
increase <=7.5 mg/week
90 mg/day
Adjunct to antiepileptic drugs
Children 9-12 yr
7.5 mg BID
increase <=7.5 mg/week
60 mg/day
Titration Epilepsy adjunct: increase by no more than 7.5 mg per week
Renal Undefined
Hepatic Undefined
Instructions
Discontinue by gradual taper to avoid withdrawal reactions
Elderly or debilitated: initiate at 7.5-15 mg/day
Anxiety: may be given as a single 15 mg dose at bedtime
Contraindications
Acute narrow-angle glaucoma
Cautions
CNS depression/drowsiness; impaired driving and machine operation
Respiratory depression with opioids/CNS depressants